Close

Aurinia Pharmaceuticals (AUPH) PT Raised to $30 at H.C. Wainwright

December 18, 2020 7:01 AM EST Send to a Friend
H.C. Wainwright analyst Ed Arce raised the price target on Aurinia Pharmaceuticals (NASDAQ: AUPH) to $30.00 while maintaining a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login